Page 50«..1020..49505152..6070..»

Stem Cell Factor Tied to Reduced Risk of Cardiac Events, Death – Anti Aging News

Stell Cell Research | Posted by admin
Sep 08 2017

407 0 Posted on Sep 07, 2017, 9 a.m.

CReM Honored for Sharing Stem Cell Lines – BU Today

Stell Cell Research | Posted by admin
Sep 08 2017

Darrell Kotton, Gustavo Mostoslavsky, and George Murphy began the Center for Regenerative Medicine (CReM) in 2008 with a mission.

Italian scientists welcome surprise 400 million boost for basic research – Science Magazine

Stell Cell Research | Posted by admin
Sep 08 2017

Italian Minister for Education, University, and Research Valeria Fedeli AP Photo/Luca Bruno By Marta PaterliniSep. 7, 2017 , 4:50 PM Plagued by budget cuts and attacks on science, Italian scientists have had little to cheer about recently.

Takeda, Noile-Immune Sign CAR-T Cell Therapy Deal – Genetic Engineering & Biotechnology News

Uncategorized | Posted by admin
Sep 06 2017

Takeda Pharmaceutical inked a collaboration agreement with Tokyo-based Noile-Immune Biotech to develop next-generation anticancer chimeric antigen receptor T-cell (CAR-T) immunotherapies based on CAR-T technology developed by Yamaguchi Universitys Koji Tamada, M.D., Ph.D., and licensed exclusively to Noile-Immune. The firms say the CAR-T therapy generates molecules, including cytokines and chemokines, that are expected to influence or change the microenvironment of solid tumors to boost antitumor efficacy. They project using the technology to discover and develop CAR-T immunotherapies against a broad range of cancers

Spain OKs TiGenix’s bigger cell therapy plant as firm preps for Cx601 – BioPharma-Reporter.com

Uncategorized | Posted by admin
Sep 06 2017

Spain has licensed TiGenix NV's expanded Madrid plant paving the way for a potential European launch of Cx601, its cell therapy forthe Crohn's disease complications. Belgium-based TiGenix announced it received the Spanish Medicines Agency (AEMPS) license this week, explaining the Madrid plant will provide capacity for production of its portfolio of cell therapies including the candidate cell therapy Cx601. Chief technical officer Wilfried Dalemans said: We have now significantly increased our manufacturing capacity, a key step in the preparation for commercialization of Cx601 in Europe and in the further development of our pipeline

Patient’s immune status associated with outcome following third-generation CAR T-cell therapy – Medical Xpress

Uncategorized | Posted by admin
Sep 06 2017

September 6, 2017 Treatment with third-generation CAR Tcell therapy led to a complete response in six of 15 patients with a CD19-positive B-cell malignancy and overall survival was associated with the patient's immune status, according to data from a phase I/IIa clinical trial presented at the Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 69. "CD19-specific CAR Tcell therapy has yielded remarkable response rates for patients who have B-cell acute lymphoblastic leukemia," said Tanja Lvgren, PhD, a researcher in the Department of Immunology, Genetics and Pathology at Uppsala University in Sweden.

Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty – PR Newswire (press release)

Uncategorized | Posted by admin
Sep 06 2017

The clinical trial is designed to enroll 120 subjects from approximately 10 medical centers around the U.S. The primary objective of the study is to evaluate the effect that LMSCs have on functional mobility and exercise tolerance in elderly Aging Frailty subjects

Zika Virus Could One Day Help Treat A Deadly Form Of Brain Cancer – HuffPost

Stell Cell Research | Posted by admin
Sep 06 2017

Glioblastoma, the aggressive and hard to treat brain cancer that Sen. John McCain (R-Ariz.) announced he was diagnosed with in July, is the target of new research using a surprising treatment:Zika virus. About 12,000 people are diagnosed with glioblastomas each year in the United States.

Curved substrates restrict spreading and induce differentiation of stem cells – Phys.Org

Stell Cell Research | Posted by admin
Sep 06 2017

September 6, 2017 by Adam Lowenstein, Florida Institute Of Technology Credit: Biotechnology Journal An invention by Florida Institute of Technology's Shengyuan Yang was found to naturally narrow the spreading of stem cells and has the potential to induce and regulate their differentiation. Using Yang's patented and patent-pending technology, stem cells were grown on microscopic glass balls immobilized in a gel medium.

This New, Cutting-Edge Treatment Could Be the End of Baldness – Reader’s Digest

Stell Cell Research | Posted by admin
Sep 06 2017

docent/ShutterstockWhether or not theres a scientific benefit to being baldwell let the follically challenged among us be the judge of thatscientists continue to search for a balding cure. According to UCLA researchers, that isnt completely out of the question



Page 50«..1020..49505152..6070..»